Phase II Randomized Study of BAX2398 in Combination With 5-Fluorouracil and Calcium Levofolinate in Japanese Patients With Metastatic Pancreatic Cancer, Which Progressed or Recurred After Prior Gemcitabine-Based Therapy
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 20 Oct 2017
At a glance
- Drugs Irinotecan (Primary) ; Fluorouracil; Levofolinic acid
- Indications Pancreatic cancer
- Focus Therapeutic Use
- Sponsors Baxalta; Shire
- 10 Jun 2017 Biomarkers information updated
- 05 Apr 2017 Status changed from recruiting to active, no longer recruiting.
- 05 Apr 2016 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.